美国心脏移植的最新进展。

Clinical transplants Pub Date : 2014-01-01

Matthew J Everly

{"title":"美国心脏移植的最新进展。","authors":"Matthew J Everly","doi":"","DOIUrl":null,"url":null,"abstract":"Heart transplantation in the United States remains an important option for those with heart failure. Survival rates over the last 25 years have improved with the advent of newer immunosuppressive agents, innovation, and a better understanding of managing risk. However, many patients continue to experience allograft failure after transplantation. Innovations in modalities to reduce acute and chronic rejection are needed to improve the long-term success of heart transplantation.","PeriodicalId":77074,"journal":{"name":"Clinical transplants","volume":" ","pages":"27-32"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Update on Cardiac Transplantation in the United States.\",\"authors\":\"Matthew J Everly\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Heart transplantation in the United States remains an important option for those with heart failure. Survival rates over the last 25 years have improved with the advent of newer immunosuppressive agents, innovation, and a better understanding of managing risk. However, many patients continue to experience allograft failure after transplantation. Innovations in modalities to reduce acute and chronic rejection are needed to improve the long-term success of heart transplantation.\",\"PeriodicalId\":77074,\"journal\":{\"name\":\"Clinical transplants\",\"volume\":\" \",\"pages\":\"27-32\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical transplants\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical transplants","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在美国，心脏移植仍然是心力衰竭患者的重要选择。在过去的25年里，随着新的免疫抑制剂的出现、创新和对风险管理的更好理解，生存率有所提高。然而，许多患者在移植后仍然经历同种异体移植物衰竭。为了提高心脏移植的长期成功，需要在减少急性和慢性排斥反应的方式上进行创新。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

An Update on Cardiac Transplantation in the United States.

Heart transplantation in the United States remains an important option for those with heart failure. Survival rates over the last 25 years have improved with the advent of newer immunosuppressive agents, innovation, and a better understanding of managing risk. However, many patients continue to experience allograft failure after transplantation. Innovations in modalities to reduce acute and chronic rejection are needed to improve the long-term success of heart transplantation.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical transplants

自引率

0.00%

发文量